Hybridoma Development

One of the key challenges of current biological research is that of developing monoclonal antibodies with desired specificity and affinity.

Aragen Bioscience has successfully developed several hundred monoclonal antibodies against a wide range of proteins and peptides for research, diagnostic and therapeutic applications.

We can customize any project to meet the specific needs of the client. This customization can include various immunization protocols, the number of final clones cryopreserved, and/or affinity assesment by the Forte Bio Octet system. We often find that many of our hybridoma customers also use our Bio-Production services to generate purified monoclonal antibodies for their purposes.